A vs RNAC · P/E 29, rev $1.88B vs P/E 2.1, rev $38.9M
Agilent Technologies Inc (A) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
A currently screens at market cap $33.70B and trailing P/E 29.2. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the A and RNAC stock pages for the full models.
Not investment advice.